Pivalylbenzhydrazine

Pivhydrazine

Pivhydrazine

Chemical compound

Pivhydrazine (trade name Tersavid), also known as pivalylbenzhydrazine and pivazide, is an irreversible and non-selective monoamine oxidase inhibitor (MAOI) of the hydrazine family. It was formerly used as an antidepressant in the 1960s, but has since been discontinued.[1][2][3]

Quick Facts Clinical data, Other names ...

See also

References

  1. [1]
    Herman ZS, Sokola A, Lenartowicz H, Zieliński M, Depta L (May–June 1976). "The influence of antidepressive drugs on the level of acetylcholine and on the acetylcholinesterase activity in the brain of rats". Polish Journal of Pharmacology and Pharmacy. 28 (4): 313–21. OCLC 1586290. PMID 981020.
  2. [2]
    Bolton GC, Griffiths LA (November–December 1979). "The metabolic disposition of [14C]pivhydrazine, [14C]mebanazine, and [14C]benzylhydrazine in the rat". Drug Metabolism and Disposition. 7 (6): 388–92. OCLC 1784380. PMID 43225.
  3. [3]
    Mikhaĭlova TV, Gilev AP, Khavronina-Gureeva ZP (1969). "[Central effects of betamezide]". Farmakologiia I Toksikologiia (in Russian). 32 (6): 652–6. OCLC 1568906. PMID 5381593.
Stub icon

This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it.
Share this article:

This article uses material from the Wikipedia article Pivalylbenzhydrazine, and is written by contributors. Text is available under a CC BY-SA 4.0 International License; additional terms may apply. Images, videos and audio are available under their respective licenses.